Encouraged By Early Clinical Studies, A Biotech Company Expands Its HIV/AIDS Vaccine Program

Based in Atlanta, GeoVax Labs, Inc. is a biotechnology company developing human vaccines for diseases caused by HIV and other infectious agents. Now the company has decided to expand its preventative HIV/AIDS vaccine development effort in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) and the HIV Vaccine Trials Network (HVTN)...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/46FtHwvXiNI/222132.php

health fitness